Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Elevated Serum TFF3 Levels in Gastric Cancer Patients Linked to Hepatic Source

  • By

  • Komei Kuge

  • Junko Mukohyama

  • Yoshimi Yasukawa

  • Yuko Ishibashi

  • Hiroki Masuda

  • Tomohiko Yasuda

  • Yasukazu Ohmoto

  • Hideyuki Takeshima

  • Akihisa Matsuda

  • Hiroshi Yoshida

  • Yasuyuki Seto

  • James R. Goldenring

  • Toshikazu Ushijima

  • Sachiyo Nomura

  • August 25, 2026

Share

  • 1

    A correction was issued for the article with DOI 10.1007/s10120-026-01782-3 in Gastric Cancer.

  • 2

    The author's name was incorrectly listed as Junko Mukoyama.

  • 3

    The correct name of the author is Junko Mukohyama.

  • 4

    The original article has been corrected to reflect this change.

  • 5

    This correction addresses an error in the authorship of the published article.

Original Source(s)

Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

  • by Komei Kuge, Junko Mukohyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura

  • August 25, 2026

Related Content

Implementation Strategies in Cascade Genetic Testing—The Devil Is in the Details

Cognitive Behavior vs Bright Light Therapy for Insomnia in Women Undergoing Chemotherapy for Breast Cancer: A

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer